Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Neurologic complications of influenza.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
[American Academy of Neurology, Washington, 18-25 April 2015].
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Deafness in Patients with Multiple Sclerosis.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Multiple sclerosis, solitary sclerosis or something else?
Combined oral contraceptives: health benefits beyond contraception.
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Systematic localization of common disease-associated variation in regulatory DNA.
Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.

Pages